HEADER HYDROLASE/HYDROLASE INHIBITOR 12-OCT-06 2IPH TITLE X-RAY STRUCTURE AT 1.75 A RESOLUTION OF A NOROVIRUS PROTEASE LINKED TO TITLE 2 AN ACTIVE SITE DIRECTED PEPTIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: THIOL PROTEASE P3C; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3C-LIKE PROTEASE, 3C-PRO; COMPND 5 EC: 3.4.22.-; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SOUTHAMPTON VIRUS (SEROTYPE 3); SOURCE 3 ORGANISM_TAXID: 37129; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PT7 KEYWDS BETA BARREL, ALPHA HELIX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.J.HUSSEY REVDAT 3 20-JUN-12 2IPH 1 JRNL HEADER KEYWDS VERSN REVDAT 2 24-FEB-09 2IPH 1 VERSN REVDAT 1 23-OCT-07 2IPH 0 JRNL AUTH R.J.HUSSEY,L.COATES,R.S.GILL,P.T.ERSKINE,S.F.COKER, JRNL AUTH 2 E.MITCHELL,J.B.COOPER,S.WOOD,R.BROADBRIDGE,I.N.CLARKE, JRNL AUTH 3 P.R.LAMBDEN,P.M.SHOOLINGIN-JORDAN JRNL TITL A STRUCTURAL STUDY OF NOROVIRUS 3C PROTEASE SPECIFICITY: JRNL TITL 2 BINDING OF A DESIGNED ACTIVE SITE-DIRECTED PEPTIDE JRNL TITL 3 INHIBITOR. JRNL REF BIOCHEMISTRY V. 50 240 2011 JRNL REFN ISSN 0006-2960 JRNL PMID 21128685 JRNL DOI 10.1021/BI1008497 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.40 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 51760 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2580 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 937 REMARK 3 BIN R VALUE (WORKING SET) : 0.2960 REMARK 3 BIN FREE R VALUE : 0.3240 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 49 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2667 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 104 REMARK 3 SOLVENT ATOMS : 247 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.28100 REMARK 3 B22 (A**2) : -4.34800 REMARK 3 B33 (A**2) : 4.62900 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.364 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.257 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.936 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.934 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 46.77 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : PEPTIDE2.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2IPH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-NOV-06. REMARK 100 THE RCSB ID CODE IS RCSB039854. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-APR-04; NULL REMARK 200 TEMPERATURE (KELVIN) : NULL; NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : ESRF; ESRF REMARK 200 BEAMLINE : ID23-1; ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; NULL REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625,0.97925,0.97955; 0.9340 REMARK 200 MONOCHROMATOR : NULL; NULL REMARK 200 OPTICS : NULL; NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD; NULL REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH; NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55934 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 36.491 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : 0.05300 REMARK 200 FOR THE DATA SET : 8.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.8 REMARK 200 DATA REDUNDANCY IN SHELL : 5.20 REMARK 200 R MERGE FOR SHELL (I) : 0.62300 REMARK 200 R SYM FOR SHELL (I) : 0.62300 REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD; NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.74850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.73550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.05300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 60.73550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.74850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.05300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 1181 REMARK 465 ALA B 2001 REMARK 465 PRO B 2002 REMARK 465 PRO B 2003 REMARK 465 GLU B 2181 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A1148 -117.01 62.31 REMARK 500 ALA B2148 -115.30 64.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LGG A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LGG B 1 DBREF 2IPH A 1001 1181 UNP Q04544 POLN_SOUV3 1100 1280 DBREF 2IPH B 2001 2181 UNP Q04544 POLN_SOUV3 1100 1280 SEQRES 1 A 181 ALA PRO PRO THR LEU TRP SER ARG VAL THR LYS PHE GLY SEQRES 2 A 181 SER GLY TRP GLY PHE TRP VAL SER PRO THR VAL PHE ILE SEQRES 3 A 181 THR THR THR HIS VAL ILE PRO THR SER ALA LYS GLU PHE SEQRES 4 A 181 PHE GLY GLU PRO LEU THR SER ILE ALA ILE HIS ARG ALA SEQRES 5 A 181 GLY GLU PHE THR LEU PHE ARG PHE SER LYS LYS ILE ARG SEQRES 6 A 181 PRO ASP LEU THR GLY MET ILE LEU GLU GLU GLY CYS PRO SEQRES 7 A 181 GLU GLY THR VAL CYS SER VAL LEU ILE LYS ARG ASP SER SEQRES 8 A 181 GLY GLU LEU LEU PRO LEU ALA VAL ARG MET GLY ALA ILE SEQRES 9 A 181 ALA SER MET ARG ILE GLN GLY ARG LEU VAL HIS GLY GLN SEQRES 10 A 181 SER GLY MET LEU LEU THR GLY ALA ASN ALA LYS GLY MET SEQRES 11 A 181 ASP LEU GLY THR ILE PRO GLY ASP CYS GLY ALA PRO TYR SEQRES 12 A 181 VAL TYR LYS ARG ALA ASN ASP TRP VAL VAL CYS GLY VAL SEQRES 13 A 181 HIS ALA ALA ALA THR LYS SER GLY ASN THR VAL VAL CYS SEQRES 14 A 181 ALA VAL GLN ALA SER GLU GLY GLU THR THR LEU GLU SEQRES 1 B 181 ALA PRO PRO THR LEU TRP SER ARG VAL THR LYS PHE GLY SEQRES 2 B 181 SER GLY TRP GLY PHE TRP VAL SER PRO THR VAL PHE ILE SEQRES 3 B 181 THR THR THR HIS VAL ILE PRO THR SER ALA LYS GLU PHE SEQRES 4 B 181 PHE GLY GLU PRO LEU THR SER ILE ALA ILE HIS ARG ALA SEQRES 5 B 181 GLY GLU PHE THR LEU PHE ARG PHE SER LYS LYS ILE ARG SEQRES 6 B 181 PRO ASP LEU THR GLY MET ILE LEU GLU GLU GLY CYS PRO SEQRES 7 B 181 GLU GLY THR VAL CYS SER VAL LEU ILE LYS ARG ASP SER SEQRES 8 B 181 GLY GLU LEU LEU PRO LEU ALA VAL ARG MET GLY ALA ILE SEQRES 9 B 181 ALA SER MET ARG ILE GLN GLY ARG LEU VAL HIS GLY GLN SEQRES 10 B 181 SER GLY MET LEU LEU THR GLY ALA ASN ALA LYS GLY MET SEQRES 11 B 181 ASP LEU GLY THR ILE PRO GLY ASP CYS GLY ALA PRO TYR SEQRES 12 B 181 VAL TYR LYS ARG ALA ASN ASP TRP VAL VAL CYS GLY VAL SEQRES 13 B 181 HIS ALA ALA ALA THR LYS SER GLY ASN THR VAL VAL CYS SEQRES 14 B 181 ALA VAL GLN ALA SER GLU GLY GLU THR THR LEU GLU HET LGG A 1 52 HET LGG B 1 52 HETNAM LGG N-ACETYL-L-ALPHA-GLUTAMYL-L-PHENYLALANYL-L-GLUTAMINYL- HETNAM 2 LGG N-[(1S)-4-AMINO-1-(2-CARBOXYETHYL)-4-OXOBUTYL]-L- HETNAM 3 LGG LEUCINAMIDE FORMUL 3 LGG 2(C34 H51 N7 O11) FORMUL 5 HOH *247(H2 O) HELIX 1 1 PRO A 1002 SER A 1007 1 6 HELIX 2 2 HIS A 1030 ILE A 1032 5 3 HELIX 3 3 THR B 2004 ARG B 2008 1 5 HELIX 4 4 HIS B 2030 ILE B 2032 5 3 SHEET 1 A 5 VAL A1009 PHE A1012 0 SHEET 2 A 5 GLY A1015 TRP A1019 -1 O GLY A1017 N THR A1010 SHEET 3 A 5 VAL A1024 THR A1028 -1 O ILE A1026 N PHE A1018 SHEET 4 A 5 PHE A1055 PHE A1060 -1 O PHE A1058 N PHE A1025 SHEET 5 A 5 ILE A1047 ALA A1052 -1 N ALA A1052 O PHE A1055 SHEET 1 B 2 GLU A1038 PHE A1039 0 SHEET 2 B 2 GLU A1042 PRO A1043 -1 O GLU A1042 N PHE A1039 SHEET 1 C 8 ILE A1072 LEU A1073 0 SHEET 2 C 8 ASP A1150 ALA A1160 1 O VAL A1153 N ILE A1072 SHEET 3 C 8 THR A1166 ALA A1170 -1 O ALA A1170 N VAL A1156 SHEET 4 C 8 ARG A1112 LEU A1121 -1 N GLY A1119 O VAL A1167 SHEET 5 C 8 LEU A1094 ILE A1109 -1 N GLY A1102 O SER A1118 SHEET 6 C 8 VAL A1082 LYS A1088 -1 N ILE A1087 O LEU A1095 SHEET 7 C 8 PRO A1142 ARG A1147 -1 O VAL A1144 N SER A1084 SHEET 8 C 8 ASP A1150 ALA A1160 -1 O ASP A1150 N ARG A1147 SHEET 1 D 5 VAL B2009 PHE B2012 0 SHEET 2 D 5 GLY B2015 TRP B2019 -1 O GLY B2017 N THR B2010 SHEET 3 D 5 VAL B2024 THR B2028 -1 O ILE B2026 N PHE B2018 SHEET 4 D 5 PHE B2055 PHE B2060 -1 O PHE B2058 N PHE B2025 SHEET 5 D 5 ILE B2047 ALA B2052 -1 N HIS B2050 O LEU B2057 SHEET 1 E 2 GLU B2038 PHE B2039 0 SHEET 2 E 2 GLU B2042 PRO B2043 -1 O GLU B2042 N PHE B2039 SHEET 1 F 8 ILE B2072 LEU B2073 0 SHEET 2 F 8 ASP B2150 ALA B2160 1 O VAL B2153 N ILE B2072 SHEET 3 F 8 THR B2166 ALA B2170 -1 O ALA B2170 N VAL B2156 SHEET 4 F 8 ARG B2112 LEU B2121 -1 N GLY B2119 O VAL B2167 SHEET 5 F 8 LEU B2094 ILE B2109 -1 N GLY B2102 O SER B2118 SHEET 6 F 8 VAL B2082 LYS B2088 -1 N ILE B2087 O LEU B2095 SHEET 7 F 8 PRO B2142 ARG B2147 -1 O VAL B2144 N SER B2084 SHEET 8 F 8 ASP B2150 ALA B2160 -1 O VAL B2152 N TYR B2145 LINK SG CYS A1139 C30 LGG A 1 1555 1555 1.80 LINK SG CYS B2139 C30 LGG B 1 1555 1555 1.80 SITE 1 AC1 27 HIS A1030 MET A1107 ILE A1109 GLN A1110 SITE 2 AC1 27 ARG A1112 THR A1134 ILE A1135 PRO A1136 SITE 3 AC1 27 GLY A1137 CYS A1139 HIS A1157 ALA A1158 SITE 4 AC1 27 ALA A1159 ALA A1160 THR A1161 THR A1166 SITE 5 AC1 27 VAL A1168 HOH A1184 HOH A1195 HOH A1235 SITE 6 AC1 27 HOH A1243 HOH A1271 HOH A1275 HOH A1287 SITE 7 AC1 27 SER B2106 MET B2107 ARG B2108 SITE 1 AC2 22 HIS B2030 ILE B2109 GLN B2110 ARG B2112 SITE 2 AC2 22 THR B2134 ILE B2135 PRO B2136 GLY B2137 SITE 3 AC2 22 CYS B2139 HIS B2157 ALA B2158 ALA B2159 SITE 4 AC2 22 ALA B2160 THR B2161 LYS B2162 THR B2166 SITE 5 AC2 22 VAL B2168 HOH B2192 HOH B2219 HOH B2225 SITE 6 AC2 22 HOH B2269 HOH B2285 CRYST1 49.497 84.106 121.471 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020203 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011890 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008232 0.00000